The latest health and social care news and a look at research and development into the treatment of common and rare diseases alike. We also look at the vital changes being made to help deliver effective healthcare through the digital transformation within the NHS.
John Wallace, Managing Director of Mile High Labs, International, shares with us why CBD continues to be one of the most exciting new products to hit the marketplace and focuses here on some significant numbers in the field.
Here, we find out about the highest-scoring supplier – Jones AV Ltd, who discuss the New SBS Framework: Audio Visual Solutions and Integrated Operating Theatres.
Herman de Jong from the University of Groningen, explores health and human welfare in the 20th century, with a focus on escaping early death, poverty and poor health.
Ahead of World Hepatitis Day on 28th July 2019, the WHO Regional Office for Africa detail the key issues when it comes to the burden of viral hepatitis in the WHO Region of Africa.
Regina Fluhrer from the University of Augsburg and Bernd Schröder from the TU in Dresden discuss the potential of intramembrane proteases as targets for cancer therapies.
José Inácio Faria MEP, Group of the European People’s Party (Christian Democrats) explains the approach of taking advantage of the EU scale to improve national healthcare systems.
Romola Davenport and Richard Smith, Cambridge Group for the History of Population and Social Structure, Department of Geography, University of Cambridge, explore the history and evolution of public health, in this article.
Here, General Manager Bart den Hertog, introduces MariPharm, the world’s first medicinal cannabis business, highlighting the company’s major milestone moments, its clinical trial process and recommended product dosage.
Jon Ander Gómez and Monica Caballero, DeepHealth Technical Manager and Project Coordinator, lift the lid on an exciting project that concerns deep-learning and high performance computing to boost biomedical applications for health.
Thanks to the economic and social progress we have made, life expectancy has increased. However, ageing often comes with health issues and restricted mobility – a challenge not only for the elderly and their families but also for society.
Transcending morphology, magnetic resonance techniques can be utilised to shed light on processes on the molecular level to unveil pathological alterations preceding anatomical and functional manifestations of (cardiovascular) diseases, in the view of Ulrich Flögel from Heinrich Heine University Düsseldorf, Germany.
Dr Richard Angell and Dr Jane Kinghorn from the Drug Discovery Group (Translational Research Office), at University College London (UCL), explain the value of drug discovery in academia in bridging the “Valley of Death”.
